...
search icon
nxtc-img

NextCure  Inc Share Price

NXTC
NSQ
$13.21
+$0.11
(0.84%)
1D
Industry: Biotechnology Sector: Health Care

NextCure  Inc Analyst Forecast

NextCure  Inc Share Price Chart

NextCure  Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$45.92M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
6.33K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.55
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.69 L
$15.74 H
$13.21

About NextCure  Inc, Common Stock

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland. more

Industry: BiotechnologySector: Health Care

NextCure  Inc Stock Returns

Time FrameNXTCSectorS&P500
1-Week Return7.84%1.51%-1.5%
1-Month Return-0.45%1.46%0.6%
3-Month Return30.21%3.94%2.43%
6-Month Return151.14%16.03%6.01%
1-Year Return50.59%9.1%11.48%
3-Year Return-30.33%19.46%67.52%
5-Year Return-91.78%35.29%73.75%
10-Year Return-94.47%137.42%254.46%

NextCure  Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue22.38M----[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue46.55K4.30M4.48M3.68M2.87M[{"date":"2020-12-31","value":1.04,"profit":true},{"date":"2021-12-31","value":95.98,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.23,"profit":true},{"date":"2024-12-31","value":63.95,"profit":true}]
Gross Profit22.38M(4.30M)(4.48M)(3.68M)(2.87M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-19.22,"profit":false},{"date":"2022-12-31","value":-20.02,"profit":false},{"date":"2023-12-31","value":-16.46,"profit":false},{"date":"2024-12-31","value":-12.8,"profit":false}]
Gross Margin100.00%----[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses63.60M70.77M75.91M67.64M59.75M[{"date":"2020-12-31","value":83.79,"profit":true},{"date":"2021-12-31","value":93.22,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":89.1,"profit":true},{"date":"2024-12-31","value":78.71,"profit":true}]
Operating Income(41.23M)(70.77M)(75.91M)(67.64M)(59.75M)[{"date":"2020-12-31","value":-4122500000,"profit":false},{"date":"2021-12-31","value":-7076500000,"profit":false},{"date":"2022-12-31","value":-7590900000,"profit":false},{"date":"2023-12-31","value":-6763700000,"profit":false},{"date":"2024-12-31","value":-5974800000,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income(36.60M)(69.39M)(74.73M)(62.72M)(55.65M)[{"date":"2020-12-31","value":-3660300000,"profit":false},{"date":"2021-12-31","value":-6938900000,"profit":false},{"date":"2022-12-31","value":-7473300000,"profit":false},{"date":"2023-12-31","value":-6272300000,"profit":false},{"date":"2024-12-31","value":-5565400000,"profit":false}]
Income Taxes(3.41M)6.96M(5.30M)--[{"date":"2020-12-31","value":-49.04,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-76.16,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(36.60M)(69.39M)(74.73M)(65.56M)(55.65M)[{"date":"2020-12-31","value":-3660300000,"profit":false},{"date":"2021-12-31","value":-6938900000,"profit":false},{"date":"2022-12-31","value":-7473300000,"profit":false},{"date":"2023-12-31","value":-6555600000,"profit":false},{"date":"2024-12-31","value":-5565400000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(33.19M)(69.39M)(69.43M)(62.72M)(55.65M)[{"date":"2020-12-31","value":-3319000000,"profit":false},{"date":"2021-12-31","value":-6938900000,"profit":false},{"date":"2022-12-31","value":-6943300000,"profit":false},{"date":"2023-12-31","value":-6272300000,"profit":false},{"date":"2024-12-31","value":-5565400000,"profit":false}]
EPS (Diluted)(1.33)(2.51)(2.69)(2.25)(1.98)[{"date":"2020-12-31","value":-133,"profit":false},{"date":"2021-12-31","value":-251,"profit":false},{"date":"2022-12-31","value":-269,"profit":false},{"date":"2023-12-31","value":-225,"profit":false},{"date":"2024-12-31","value":-198,"profit":false}]

NextCure  Inc Ratios

NextCure  Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

NXTC
Cash Ratio 2.65
Current Ratio 2.97

NextCure  Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NXTC
ROA (LTM) -58.01%
ROE (LTM) -116.91%

NextCure  Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NXTC
Debt Ratio Lower is generally better. Negative is bad. 0.40
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.60

NextCure  Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NXTC
Trailing PE NM
Forward PE NM
P/S (TTM) 9.52
P/B 1.93
Price/FCF NM
EV/R 1.62
EV/Ebitda 0.51

FAQs

What is NextCure  Inc share price today?

NextCure  Inc (NXTC) share price today is $13.21

Can Indians buy NextCure  Inc shares?

Yes, Indians can buy shares of NextCure  Inc (NXTC) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NXTC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of NextCure  Inc be purchased?

Yes, you can purchase fractional shares of NextCure  Inc (NXTC) via the Vested app. You can start investing in NextCure  Inc (NXTC) with a minimum investment of $1.

How to invest in NextCure  Inc shares from India?

You can invest in shares of NextCure  Inc (NXTC) via Vested in three simple steps:

  • Click on Sign Up or Invest in NXTC stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in NextCure  Inc shares
What is NextCure  Inc 52-week high and low stock price?

The 52-week high price of NextCure  Inc (NXTC) is $15.74. The 52-week low price of NextCure  Inc (NXTC) is $2.69.

What is NextCure  Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of NextCure  Inc (NXTC) is

What is NextCure  Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of NextCure  Inc (NXTC) is 1.93

What is NextCure  Inc dividend yield?

The dividend yield of NextCure  Inc (NXTC) is 0.00%

What is the Market Cap of NextCure  Inc?

The market capitalization of NextCure  Inc (NXTC) is $45.92M

What is NextCure  Inc's stock symbol?

The stock symbol (or ticker) of NextCure  Inc is NXTC

How Can Investors Use NextCure  Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of NextCure  Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether NextCure  Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from NextCure  Inc shares for Indian investors?

When investing in NextCure  Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the NextCure  Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare NextCure  Inc share price with other stocks in the same sector?

Rather than merely checking the share price of NextCure  Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that NextCure  Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top